MetLife Q1 2026 Earnings Call Summary

1Key Financial Results and Metrics

Adjusted Earnings: $1.6 billion, or $2.42 per share, an 18% increase year-over-year; adjusted EPS rose 23%.

Net Income: $1.1 billion, or $1.74 per share, impacted by net investment losses.

Adjusted Premiums, Fees, and Other Revenues: Increased by 10% year-over-year.

Variable Investment Income: $518 million, driven by strong private equity returns (2.9%).

Adjusted Return on Equity: 17%, at the top end of the target range (15%-17%).

Direct Expense Ratio: 11.9%, better than the full-year target of 12.1%.

2Strategic Updates and Business Highlights

MetLife's New Frontier strategy is in its second year, focusing on accelerating growth across diversified businesses.

Group Benefits: Adjusted earnings of $439 million, up 19% year-over-year, with strong sales growth (15%).

Retirement & Income Solutions (RIS): Adjusted earnings of $451 million, up 11%, supported by strong variable investment income.

Asia: Outstanding performance with adjusted earnings of $487 million, a 31% increase, and 22% sales growth on a constant currency basis.

Latin America: Adjusted earnings of $229 million, up 5%, with strong sales growth (20%).

EMEA: Adjusted earnings of $110 million, up 33%, driven by strong sales across multiple markets.

MetLife Investment Management (MIM): Adjusted earnings of $47 million, a 68% increase, following the PineBridge acquisition.

3Forward Guidance and Outlook

MetLife expects continued strong performance across its segments, with a focus on disciplined capital management and expense control.

The company anticipates full-year adjusted earnings for RIS to be between $1.6 billion and $1.8 billion.

The outlook remains positive, with strong demand for products in key markets and a robust pipeline in MIM.

4Bad News, Challenges, or Points of Concern

Investment Losses: The difference between net income and adjusted earnings was primarily due to net investment losses from trading activity.

Market Volatility: Institutional client outflows in MIM were attributed to market depreciation and platform integration challenges.

Regulatory Scrutiny: MetLife is addressing regulatory issues in Japan, which could impact operations, though no immediate effects on business results were reported.

Expense Management: While the direct expense ratio improved, the integration of PineBridge has introduced higher structural expenses.

5Notable Q&A Insights

Group Life Mortality Trends: Management noted favorable working-age mortality trends but indicated that sustainability of these trends is uncertain and will require careful monitoring.

Japan Sales Dynamics: Strong sales growth in Japan was attributed to successful product launches and distribution strength, with expectations for continued momentum despite potential moderation.

Disability Claims: Higher claims were noted due to new state-mandated paid family leave programs, but management does not foresee a need for overall repricing at this time.

MIM Pipeline: The integration of PineBridge is progressing well, with positive feedback from clients and a strong pipeline for new commitments. Overall, MetLife reported a strong start to 2026, with broad-based growth across its segments and a disciplined approach to capital management, despite facing some market volatility and regulatory challenges.